{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for vitamin root_notes_note in Note (approximate match)
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:exidavnemab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03789604: Phase 3 Interventional Active, not recruiting Non Small Cell Lung Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:dalutrafusp alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03849469: Phase 1 Interventional Completed Melanoma
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01899599: Phase 2 Interventional Completed Ovarian Epithelial Cancer Recurrent
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:futermestotug [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00117936: Phase 2 Interventional Unknown status Coronary Disease
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03596372: Phase 1 Interventional Completed Advanced CEACAM6-expressing Solid Tumors
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03797391: Phase 1/Phase 2 Interventional Recruiting Neoplasms
(2018)
Source URL:
Class:
PROTEIN